Drug:
Reaction: ILLNESS
20250101 - 20251231
No. 501 - 600
No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
501 | 25087663 |
US |
64 | 2 |
Subarachnoid haemorrhage, Off label use, Pain, Tremor, Illness, Epistaxis, Dry skin, Alopecia, Rash, Arthralgia, Hypersomnia, Ill-defined disorder, Pain, |
||||
TRASTUZUMAB, TRASTUZUMAB, PACLITAXEL, |
||||
502 | 25087900 |
US |
61 | 2 |
Illness, Intercepted product dispensing error, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
503 | 25087913 |
US |
54 | 2 |
Intentional product misuse, Illness, |
||||
TADALAFIL, TREPROSTINIL, CYANOCOBALAMIN, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, NICOTINE POLACRILEX, NICOTINE, NICOTINE POLACRILEX MINI, NICOTINE POLARILEX, OXYBUTYNIN CHLORIDE, MORPHINE SULFATE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, AMITRIPTYLINE HYDROCHLORIDE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, BACLOFEN, UMECLIDINIUM, ALBUTEROL SULFATE, LINACLOTIDE, MEMANTINE HYDROCHLORIDE, OXYGEN, 0XYGEN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, SPIRONOLACTONE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, DULOXETINE HYDROCHLORIDE, DULOXETIN HYDROCHLORIDE, DULOXETINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, FUROSEMIDE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, |
||||
504 | 25087927 |
US |
||
Myocardial infarction, Illness, |
||||
DAPAGLIFLOZIN, |
||||
505 | 25088140 |
US |
||
Illness, |
||||
DAPAGLIFLOZIN, |
||||
506 | 25088179 |
US |
||
Diarrhoea, Neuropathy peripheral, Abdominal pain, Abdominal distension, Neutrophil count increased, Red blood cell count decreased, Product dose omission issue, Illness, Fatigue, Oropharyngeal pain, Pharyngeal swelling, Cough, Chest discomfort, Sinus congestion, |
||||
OLAPARIB, |
||||
507 | 25088262 |
US |
2 | |
Fall, Face injury, Illness, Hospitalisation, Eye irritation, Gastrointestinal disorder, Gait disturbance, Sedation, Persistent postural-perceptual dizziness, Blood sodium decreased, |
||||
CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, LIFITEGRAST, CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE, CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN, LEVETIRACETAM, OXCARBAZEPINE, NEBIVOLOL, NEBIVOLOL HYDROCHLORIDE, UBROGEPANT, PERFLUOROHEXYLOCTANE, OXYCODONE HYDROCHLORIDE, OXYCODONE, SERTRALINE HYDROCHLORIDE, ALBUTEROL SULFATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, LEVOTHYROXINE, GABAPENTIN, PANCRELIPASE LIPASE, PANCRELIPASE PROTEASE, PANCRELIPASE AMYLASE, SUCRALFATE, SUCRALFATE ORAL SUSPENSION, SUCRALFATE ORAL, |
||||
508 | 25088276 |
US |
2 | |
Illness, Device malfunction, |
||||
SECUKINUMAB, |
||||
509 | 25088311 |
CA |
56 | 1 |
Colitis ulcerative, Atrial fibrillation, Blindness transient, Diarrhoea, Illness, Impaired work ability, Social problem, Dizziness, Chest discomfort, Asthenia, Vomiting, Headache, Fatigue, Nausea, Sinusitis, Influenza, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, PREDNISONE, |
||||
510 | 25088414 |
US |
||
Nephrolithiasis, Illness, |
||||
RELUGOLIX, RELUGOLIX, |
||||
511 | 25088504 |
|||
Illness, Product quality issue, Nausea, |
||||
SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL CITRATE, SILDENAFIL, |
||||
512 | 25088764 |
CA |
63 | 2 |
Anaphylactic reaction, Anxiety, Aphthous ulcer, Asthenia, Asthma, Back pain, Bell^s palsy, COVID-19, Chills, Contusion, Cough, Decreased appetite, Discomfort, Dizziness, Dyspnoea, Eye haemorrhage, Eyelid ptosis, Fall, Fatigue, Feeling abnormal, Foreign body sensation in eyes, Headache, Hypertensive crisis, Hypoaesthesia, Illness, Inappropriate schedule of product administration, Injection site bruising, Injection site discomfort, Injection site pain, Injection site swelling, Injury, Lacrimation increased, Lethargy, Limb discomfort, Lipoma, Loss of consciousness, Mobility decreased, Malaise, Myalgia, Oropharyngeal pain, Oxygen saturation decreased, Pain, Paralysis, Paranasal sinus discomfort, Procedural pain, Productive cough, Pyrexia, Rhinorrhoea, Sinus congestion, Sputum discoloured, Symptom recurrence, Throat clearing, Tinnitus, Upper-airway cough syndrome, Urinary incontinence, Vaccination site pain, Visual impairment, Weight decreased, |
||||
RITUXIMAB, OMALIZUMAB, OMALIZUMAB, CEFUROXIME SODIUM, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, FUROSEMIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, MOMETASONE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, SEMAGLUTIDE, MONTELUKAST SODIUM, |
||||
513 | 25088860 |
US |
2 | |
Illness, |
||||
ADALIMUMAB, |
||||
514 | 25089114 |
US |
66 | 2 |
Pneumonia, Influenza, Viral infection, Illness, |
||||
DUPILUMAB, |
||||
515 | 25089329 |
US |
76 | 2 |
Illness, Product dose omission issue, |
||||
IRON, MAGNESIUM CHLORIDE, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, MIRTAZAPINE, MAGNESIUM CHLORIDE, LEVOTHYROXINE SODIUM, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, CYANOCOBALAMIN, ERGOCALCIFEROL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ROSUVASTATIN, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
516 | 25089420 |
ZA |
78 | |
Illness, Pneumonia, |
||||
RISPERIDONE, |
||||
517 | 25089451 |
US |
64 | 2 |
Death, Headache, Illness, Vomiting, Muscle spasms, Nasopharyngitis, Diarrhoea, Blood pressure increased, |
||||
FRUQUINTINIB, FRUQUINTINIB, FRUQUINTINIB, FRUQUINTINIB, |
||||
518 | 25089478 |
US |
||
Illness, Gastroenteritis viral, Abdominal pain upper, |
||||
DULAGLUTIDE, |
||||
519 | 25090124 |
US |
1 | |
Illness, |
||||
MEPOLIZUMAB, |
||||
520 | 25090213 |
US |
65 | 2 |
Food poisoning, Lung disorder, Influenza, Cough, Gait disturbance, Asthenia, Anxiety, Myalgia, Muscle fatigue, Appetite disorder, Muscular weakness, Blood bicarbonate decreased, Pyrexia, Brain fog, Abdominal discomfort, Vision blurred, Productive cough, Feeling abnormal, Bone pain, Chest pain, Depression, Hypersomnia, Injury, Rhinorrhoea, Nasal congestion, Pain, Familial periodic paralysis, Pulmonary function test decreased, Panic reaction, Stress, Blood urea decreased, Nightmare, Carbon dioxide increased, Diaphragmatic disorder, Renal disorder, Chromaturia, Dysphagia, Illness, Aphasia, Electrocardiogram T wave abnormal, Blood creatinine increased, Blood calcium abnormal, Hypoaesthesia, Taste disorder, Paralysis, Fall, Unevaluable event, Blood potassium decreased, Syncope, Metabolic acidosis, Malaise, Fatigue, Electrocardiogram QT prolonged, Insomnia, Blood sodium decreased, Heart rate increased, Dry mouth, Nausea, Diarrhoea, Rash, Dyspnoea, Pruritus, COVID-19, Product dose omission in error, |
||||
VENLAFAXINE HYDROCHLORIDE, DICHLORPHENAMIDE, DICHLORPHENAMIDE, DICHLORPHENAMIDE, DICHLORPHENAMIDE, DICHLORPHENAMIDE, |
||||
521 | 25090476 |
US |
39 | 2 |
Illness, |
||||
TOFACITINIB, |
||||
522 | 25090578 |
US |
||
Weight decreased, Illness, |
||||
NIRMATRELVIR AND RITONAVIR, |
||||
523 | 25090591 |
ZA |
78 | |
Illness, |
||||
RISPERIDONE, ENALAPRIL MALEATE, ENALAPRIL, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, |
||||
524 | 25090734 |
CA |
51 | 2 |
Parathyroidectomy, Thyroid operation, Illness, |
||||
GOLIMUMAB, GOLIMUMAB, |
||||
525 | 25090738 |
US |
||
Diarrhoea, Gastrointestinal haemorrhage, Illness, Colostomy, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ALBUTEROL SULFATE, ALBUTEROL, |
||||
526 | 25090744 |
US |
2 | |
Illness, |
||||
SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, FISH OIL, HYDROXYCHLOROQUINE SULFATE, MOMETASONE FUROATE, MOMETASONE, ERGOCALCIFEROL, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, PREDNISONE, CETIRIZINE HYDROCHLORIDE, DEXLANSOPRAZOLE, TREPROSTINIL, TREPROSTINIL, CELECOXIB, ROSUVASTATIN, FOLIC ACID, ALBUTEROL SULFATE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, ETANERCEPT, MACITENTAN, FLUTICASONE PROPIONATE, ESOMEPRAZOLE MAGNESIUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, METHOTREXATE, METHOTREXATE SODIUM, CYCLOSPORINE, TADALAFIL, OXYGEN, 0XYGEN, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, SULFAMETHOXAZOLE AND TRIMETHOPRIM, DIGOXIN, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, AMITRIPTYLINE HYDROCHLORIDE, BENZONATATE, |
||||
527 | 25090894 |
US |
61 | 2 |
Cough, Illness, |
||||
SECUKINUMAB, |
||||
528 | 25090914 |
US |
78 | 2 |
Illness, Speech disorder, Feeding disorder, Headache, Dry mouth, Dyspepsia, Diarrhoea, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
529 | 25090993 |
CA |
26 | 2 |
Blood immunoglobulin G decreased, Pregnancy, Illness, Weight increased, Upper respiratory tract infection bacterial, Viral infection, Inappropriate schedule of product administration, Product dispensing error, Oxygen saturation abnormal, Rash maculo-papular, Fatigue, Pruritus, |
||||
HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, IRON, ERGOCALCIFEROL, |
||||
530 | 25091134 |
US |
2 | |
Illness, Bedridden, Nausea, Vomiting, Drug ineffective, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, |
||||
531 | 25091351 |
US |
1 | |
Illness, |
||||
DUPILUMAB, |
||||
532 | 25091444 |
US |
11 | 1 |
Pruritus, Rash macular, Eczema, Illness, Gastroenteritis viral, |
||||
DUPILUMAB, |
||||
533 | 25091543 |
US |
1 | |
Limb discomfort, Depression, Decreased interest, Loss of personal independence in daily activities, Illness, |
||||
SARILUMAB, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, CALCIUM, CHLORZOXAZONE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESTRADIOL, FAMOTIDINE, FENOFIBRATE, FOLIC ACID, GABAPENTIN, LAMOTRIGINE, LEVOTHYROXINE, LOSARTAN POTASSIUM, LOSARTAN, METHOTREXATE, METHOTREXATE SODIUM, NALOXONE HCL, OXYCODONE, PREDNISONE, TEMAZEPAM, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, TIRZEPATIDE, |
||||
534 | 25091672 |
US |
61 | 2 |
Illness, |
||||
INSULIN GLARGINE, |
||||
535 | 25091694 |
US |
2 | |
Illness, |
||||
DUPILUMAB, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, BUDESONIDE AND FORMOTEROL FUMARATE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LORATADINE, LORATADINE TABLET, TIRZEPATIDE, |
||||
536 | 25091922 |
US |
2 | |
Illness, Muscle spasms, |
||||
UPADACITINIB, |
||||
537 | 25094007 |
54 | 2 | |
Illness, |
||||
ETANERCEPT, |
||||
538 | 25094038 |
33 | 2 | |
Arthropathy, Nonspecific reaction, Illness, |
||||
ADALIMUMAB, |
||||
539 | 25081856 |
US |
60 | 2 |
COVID-19, Illness, Ophthalmic herpes zoster, Chronic obstructive pulmonary disease, Weight decreased, Fatigue, |
||||
SEMAGLUTIDE, DUPILUMAB, ALBUTEROL SULFATE, |
||||
540 | 25081884 |
US |
2 | 1 |
Illness, |
||||
DUPILUMAB, |
||||
541 | 25081914 |
US |
2 | |
Illness, Dyskinesia, Product dose omission issue, |
||||
BELIMUMAB, |
||||
542 | 25082018 |
US |
||
Illness, Drug dose omission by device, Product packaging quantity issue, Device delivery system issue, Device mechanical issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, |
||||
543 | 25082137 |
US |
25 | 2 |
Illness, |
||||
DUPILUMAB, |
||||
544 | 25082150 |
US |
2 | |
Illness, Aphonia, |
||||
DUPILUMAB, SERTRALINE HYDROCHLORIDE, ERGOCALCIFEROL, SIMVASTATIN, SERTRALINE HYDROCHLORIDE, RALOXIFENE, HYDROXYCHLOROQUINE SULFATE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, MOMETASONE FUROATE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, MECLIZINE HYDROCHLORIDE, MECLIZINE HCL, MECLIZINE, MAGNESIUM OXIDE, LOSARTAN POTASSIUM, LOSARTAN, FINERENONE, IRON, INSULIN LISPRO, HYDROXYCHLOROQUINE SULFATE, FLUTICASONE PROPIONATE, FENOFIBRATE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, CARVEDILOL, ATENOLOL, AMLODIPINE BESYLATE, FEXOFENADINE HYDROCHLORIDE, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, IBUPROFEN TABLET COATED, |
||||
545 | 25082176 |
US |
24 | 2 |
Illness, Pyrexia, Tachycardia, |
||||
NATALIZUMAB, |
||||
546 | 25082408 |
US |
47 | 2 |
Pain, Vomiting, Diarrhoea, Abdominal pain upper, Illness, |
||||
PANCRELIPASE, PANCRELIPASE, |
||||
547 | 25082413 |
US |
68 | |
Illness, Cough, Device leakage, Nasal congestion, |
||||
EXENATIDE, |
||||
548 | 25082454 |
US |
||
Respiratory distress, Illness, Dyspnoea, |
||||
BUDESONIDE, |
||||
549 | 25082557 |
US |
2 | |
Illness, Infection, Decreased appetite, Pain, Pruritus, Swelling, |
||||
OMALIZUMAB, |
||||
550 | 25082611 |
US |
46 | 1 |
Upper respiratory tract congestion, Illness, Upper respiratory tract infection, |
||||
DUPILUMAB, |
||||
551 | 25082650 |
US |
2 | |
Illness, Product use in unapproved indication, |
||||
SARILUMAB, AMLODIPINE BESYLATE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, HYDROCHLOROTHIAZIDE, METOPROLOL TARTRATE, METOPROLOL, AMLODIPINE BESYLATE, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, |
||||
552 | 25082705 |
US |
64 | 1 |
Viral infection, Nasal congestion, Illness, Weight decreased, |
||||
RIPRETINIB, |
||||
553 | 25082734 |
US |
||
Illness, Incorrect dose administered, Product dose omission issue, Overdose, Device malfunction, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
554 | 25082836 |
US |
||
Illness, |
||||
555 | 25082897 |
US |
1 | |
Hospitalisation, Abdominal pain upper, Constipation, Pyrexia, Illness, Vomiting, Product dose omission issue, |
||||
VAMOROLONE, VAMOROLONE, VAMOROLONE, LISINOPRIL, FAMOTIDINE, ERGOCALCIFEROL, VILTOLARSEN, POLYETHYLENE GLYCOL 3350, |
||||
556 | 25083023 |
GB |
1 | |
Illness, |
||||
VARENICLINE, VARENICLINE TARTRATE, |
||||
557 | 25083086 |
CA |
25 | 2 |
Angioedema, Anxiety, Body temperature increased, Cough, Drug hypersensitivity, Flushing, Heart rate increased, Illness, Inappropriate schedule of product administration, Nausea, Pruritus, Sinusitis, Stress, Swelling, Urticaria, Weight decreased, Weight increased, Wrong technique in product usage process, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, MONTELUKAST SODIUM, |
||||
558 | 25083204 |
US |
1 | |
Illness, Product preparation issue, Product physical issue, |
||||
559 | 25083320 |
CA |
57 | 2 |
Illness, |
||||
SECUKINUMAB, |
||||
560 | 25083363 |
US |
64 | 2 |
Illness, Vomiting, |
||||
DUPILUMAB, DUPILUMAB, |
||||
561 | 25083378 |
US |
2 | |
Illness, Neuralgia, Product dose omission issue, Headache, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, AMLODIPINE BESYLATE, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROCHLOROTHIAZIDE, LISINOPRIL, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, SUCRALFATE, SUCRALFATE ORAL SUSPENSION, SUCRALFATE ORAL, SUMATRIPTAN SUCCINATE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, |
||||
562 | 25083435 |
CA |
60 | 2 |
Contusion, Illness, Inappropriate schedule of product administration, Skin texture abnormal, |
||||
OFATUMUMAB, OFATUMUMAB, |
||||
563 | 25083878 |
US |
2 | |
Myocardial infarction, Cerebral disorder, Illness, Gastrointestinal disorder, |
||||
MIRABEGRON, |
||||
564 | 25084477 |
US |
70 | 1 |
Blood glucose increased, Illness, |
||||
INSULIN LISPRO, INSULIN DEGLUDEC, |
||||
565 | 25084502 |
US |
48 | 2 |
Cough, Illness, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
566 | 25084510 |
US |
79 | 2 |
Diarrhoea, Illness, Off label use, |
||||
567 | 25084685 |
US |
71 | 2 |
Illness, Drug ineffective, Weight increased, Hunger, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
568 | 25084785 |
US |
85 | 2 |
Illness, Product use in unapproved indication, |
||||
SARILUMAB, |
||||
569 | 25084958 |
US |
2 | |
Illness, |
||||
OFATUMUMAB, |
||||
570 | 25084964 |
US |
||
Illness, General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
571 | 25085229 |
CA |
62 | 2 |
Illness, |
||||
INCLISIRAN, |
||||
572 | 25085251 |
US |
6 | 1 |
Asthenia, Nasopharyngitis, Rhinorrhoea, Illness, |
||||
PALIVIZUMAB, |
||||
573 | 25085253 |
ZA |
84 | |
Illness, |
||||
DAPAGLIFLOZIN, SIMVASTATIN, GABAPENTIN, CARBAMAZEPINE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, |
||||
574 | 25085263 |
US |
||
Illness, Product dose omission issue, |
||||
GANAXOLONE, |
||||
575 | 25085363 |
US |
1 | |
Illness, Cough, Pyrexia, Asthenia, Off label use, |
||||
PYRIMETHAMINE, |
||||
576 | 25085549 |
GB |
2 | |
Haematochezia, Constipation, Illness, Malaise, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, |
||||
577 | 25085558 |
CA |
43 | 1 |
Haematochezia, Illness, |
||||
MESALAMINE, PANTOPRAZOLE, PREDNISONE, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, |
||||
578 | 25085806 |
US |
55 | 1 |
Illness, |
||||
DUPILUMAB, |
||||
579 | 25085856 |
US |
2 | |
Illness, |
||||
ADALIMUMAB, FOLIC ACID, METHOTREXATE, METHOTREXATE SODIUM, MORPHINE SULFATE, PREDNISONE, ZOLPIDEM TARTRATE, ERGOCALCIFEROL, |
||||
580 | 25085918 |
CA |
2 | |
Splenomegaly, Frequent bowel movements, Illness, Liver function test increased, Abdominal tenderness, Abdominal distension, Abdominal pain, Gastroenteritis viral, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, IBUPROFEN TABLET COATED, |
||||
581 | 25085976 |
US |
1 | |
Illness, |
||||
OMALIZUMAB, OMALIZUMAB, PREDNISONE, ALBUTEROL SULFATE, TRAZODONE HYDROCHLORIDE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
582 | 25085991 |
US |
57 | 2 |
Illness, Nasopharyngitis, |
||||
ABATACEPT, |
||||
583 | 25086080 |
US |
52 | 2 |
Illness, |
||||
TOFACITINIB, |
||||
584 | 25086082 |
US |
61 | 2 |
Sinusitis, Ear pain, Illness, Intentional product misuse, |
||||
TOFACITINIB, |
||||
585 | 25086165 |
US |
67 | 2 |
Illness, |
||||
TOFACITINIB, |
||||
586 | 25086226 |
US |
53 | 2 |
Illness, |
||||
TOFACITINIB, |
||||
587 | 25088191 |
35 | 2 | |
Illness, Intentional dose omission, |
||||
ETANERCEPT, |
||||
588 | 25088192 |
40 | 2 | |
Illness, |
||||
ETANERCEPT, |
||||
589 | 25088303 |
44 | 2 | |
Illness, Therapy interrupted, |
||||
ADALIMUMAB, |
||||
590 | 25088692 |
49 | 2 | |
Illness, Surgery, |
||||
UPADACITINIB, UPADACITINIB, UPADACITINIB, |
||||
591 | 25088694 |
60 | 2 | |
Illness, Therapy interrupted, |
||||
UPADACITINIB, |
||||
592 | 25081277 |
CA |
32 | 2 |
Disability, Lower respiratory tract infection, Syncope, Ear infection, Fatigue, Pharyngitis streptococcal, Migraine, Impaired work ability, Respiratory disorder, General physical health deterioration, Insurance issue, Product dose omission issue, Illness, |
||||
FREMANEZUMAB-VFRM, FREMANEZUMAB-VFRM, |
||||
593 | 25081459 |
US |
2 | |
Illness, Product dose omission issue, |
||||
MEPOLIZUMAB, |
||||
594 | 25081483 |
US |
68 | 2 |
Illness, Intentional product misuse, |
||||
DUPILUMAB, |
||||
595 | 25081510 |
US |
80 | 2 |
Illness, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
596 | 25081720 |
US |
||
Urticaria, Illness, Diarrhoea, Product use in unapproved indication, |
||||
ELACESTRANT, CAPIVASERTIB, LOPERAMIDE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROXYCHLOROQUINE SULFATE, PALBOCICLIB, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METHYLPREDNISOLONE, FAMOTIDINE, QUERCETIN, QUERCETIN,, LEVOTHYROXINE SODIUM, ERGOCALCIFEROL, VITAMIN E, CREAM, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, |
||||
597 | 25080654 |
US |
2 | |
Illness, Malaise, Nausea, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
598 | 25080690 |
US |
70 | 2 |
Illness, Pruritus, Rash, |
||||
DUPILUMAB, DUPILUMAB, |
||||
599 | 25080810 |
US |
52 | 2 |
Illness, Arthritis, Hypotension, Visual impairment, Dizziness, Arrhythmia, Headache, Sinus disorder, Fatigue, Somnolence, Discomfort, Rheumatoid arthritis, Respiratory disorder, Neck pain, Diarrhoea, Dysphagia, Cold sweat, Decreased appetite, Hypoaesthesia oral, Dyspepsia, Skin burning sensation, Pyrexia, Feeling hot, Anxiety, Angina pectoris, |
||||
UPADACITINIB, |
||||
600 | 25081042 |
US |
54 | 2 |
Ehlers-Danlos syndrome, Fatigue, Influenza, Illness, Intentional dose omission, Eczema, |
||||
DUPILUMAB, DUPILUMAB, |
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28